BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients
Catherine M. Verfaillie, Ravi Bhatia, Wesley Miller, Frank Mortari, Vivek Roy, Scott Burger, Jeff McCullough, Kevin Stieglbauer, Gordon Dewald, Shelly Heimfeld, Jeffrey S. Miller, Philip B. McGlave
Dive into the research topics of 'BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients'. Together they form a unique fingerprint.